Form 8-K - Current report:
SEC Accession No. 0001937653-25-000026
Filing Date
2025-05-08
Accepted
2025-05-08 16:08:55
Documents
15
Period of Report
2025-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zyme-20250508.htm   iXBRL 8-K 38885
2 EX-99 ex991q12025_earningsxrelea.htm EX-99 90527
6 zw_logoa.jpg GRAPHIC 13528
  Complete submission text file 0001937653-25-000026.txt   286583

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zyme-20250508.xsd EX-101.SCH 1788
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zyme-20250508_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zyme-20250508_pre.xml EX-101.PRE 12512
17 EXTRACTED XBRL INSTANCE DOCUMENT zyme-20250508_htm.xml XML 2815
Mailing Address 108 PATRIOT DRIVE, SUITE A MIDDLETOWN DE 19709
Business Address 108 PATRIOT DRIVE, SUITE A MIDDLETOWN DE 19709 302-274-8744
Zymeworks Inc. (Filer) CIK: 0001937653 (see all company filings)

EIN.: 883099146 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41535 | Film No.: 25926066
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)